- Projects & figures
- News & Events
- Managing your project
- About ERC
Over the past months, a sudden influx of ‘Pokémon Go’ players could be observed across the globe. Youngsters, people of all ages scrutinise their surroundings silently, using their smartphones to catch those digital creatures with unlikely names. How could such a phenomenon take over the world so fast? Part of the answer may be the game’s strong interaction with the real-world and its impressive mapping, offering a whole new virtual experience of spaces that seem to be familiar and yet so different.
Acetylsalicylic acid, most commonly known as aspirin, was already part of the Egyptian pharmacopeia, used also in ancient Greece and in the Middle Ages to break fevers. Taken all over the world to kill pain and reduce inflammation, today aspirin helps to prevent heart attacks, strokes and blood clots. Its emerging role in preventing and treating cancer is on the rise too. But how does this drug act on your blood cells? ERC grantee Prof Valerie O’Donnell works on the answer.
A ground-breaking anthropological discovery took place in East Africa, where ERC Advanced grantee Dr Marta Mirazón Lahr and her team have been studying human origins. At the excavation site in Nataruk in northern Kenya, they have stumbled upon a real archaeological rarity – the earliest historical evidence of warfare.
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to bring new insight into pregnancy-associated malaria, to save the lives of women and their babies in areas affected by the disease. Now, Dr Salanti’s research has shifted to battling against another deadly disease: cancer. This comes after an unexpected discovery yielded ground-breaking results for the diagnosis and treatment of this illness. This is the kind of curiosity-driven research that can lead to ground-breaking serendipitous outcomes.